Angel R. Payer
Oviedo, AS, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 27, 2025
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial.
Journal: The Lancet. Haematology
Published: January 22, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.
Journal: Leukemia
Published: January 03, 2025
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.
Journal: Annals of hematology
Published: December 02, 2023
Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.
Journal: Leukemia & lymphoma
Published: May 31, 2023
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: November 11, 2022
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
Journal: Journal of geriatric oncology
Published: May 31, 2022
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression.
Journal: Journal of clinical medicine
Published: October 09, 2020
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer.
Journal: International journal of molecular sciences
Published: April 21, 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis.
Journal: Medicina clinica
Published: August 30, 2019
Last Updated: 09/26/2026